Kyle Rybczyk
Overview
Explore the profile of Kyle Rybczyk including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
185
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kalams S, Rogers L, Smith R, Barnett L, Crumbo K, Sumner S, et al.
Eur J Contracept Reprod Health Care
. 2016 Sep;
21(6):436-442.
PMID: 27636701
Objectives: The aim of the study was to assess the extent to which misoprostol alters mucosal or systemic immune responses following either buccal or vaginal administration. Methods: This was a...
2.
Fuchs J, Frank I, Elizaga M, Allen M, Frahm N, Kochar N, et al.
Open Forum Infect Dis
. 2015 Jul;
2(3):ofv082.
PMID: 26199949
Background. We report the first-in-human safety and immunogenicity evaluation of a highly attenuated, replication-competent recombinant vesicular stomatitis virus (rVSV) human immunodeficiency virus (HIV)-1 vaccine. Methods. Sixty healthy, HIV-1-uninfected adults were...
3.
Kalams S, Parker S, Elizaga M, Metch B, Edupuganti S, Hural J, et al.
J Infect Dis
. 2013 Jul;
208(5):818-29.
PMID: 23840043
Background: DNA vaccines have been very poorly immunogenic in humans but have been an effective priming modality in prime-boost regimens. Methods to increase the immunogenicity of DNA vaccines are needed....
4.
Graham B, McElrath M, Keefer M, Rybczyk K, Berger D, Weinhold K, et al.
PLoS One
. 2010 Aug;
5(8):e11995.
PMID: 20706632
Background: A peptide vaccine was produced containing B and T cell epitopes from the V3 and C4 Envelope domains of 4 subtype B HIV-1 isolates (MN, RF, CanO, & Ev91)....